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Pseudomonas aeruginosa is a relevant opportunistic pathogen 
frequently associated with several nosocomial infections and, 
worryingly, this bacterium shows a low antibiotic susceptibility. 
One of its virulence factors is related with the ability to adhere to 
surfaces and also human epithelium and form virulent biofilms. 
This work describes the isolation and characterization of lytic 
phages capable to infect antibiotic resistant P. aeruginosa strains. 
It is also described herein the potential of the new isolated phages 
for planktonic cells and biofilm control. According to the results 
of this work, the isolated phages showed different spectra of 
activity and most of them were efficient even against P. 
aeruginosa multidrug resistant strains. Furthermore, the biofilm 
infection assays revealed that phages can be a good strategy to 
combat virulent biofilms achieving significant reductions in the 
number of biofilm cells. 
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I.  CONTEXT 
Pseudomonas aeruginosa is an ubiquitous organism which 
has emerged as a major threat in the hospital environment. 
This bacterium is the most frequently isolated Gram-negative 
organism in bloodstream and wound infections, pneumonia, 
intra-abdominal and urogenital sepsis and is a serious problem 
infecting immunocomprimised patients with cystic fibrosis 
(CF), severe burns, cancer, AIDS, etc. [1-2]. One of the most 
worrying characteristics of this bacterium is its low antibiotic 
susceptibility which can be attributed to a concerted action of 
multidrug efflux pumps with chromosomally-encoded 
antibiotic resistance genes and the low permeability of the 
bacterial cellular envelopes [3]. The overuse of antibiotics has 
also significantly increased the emergence of antimicrobial 
multi-resistant bacteria and consequently, the treatment of 
most chronical P. aeruginosa infections with antibiotics is 
notoriously difficult [3-4]. Additionally, P. aeruginosa has an 
inapt ability to adhere to surfaces and form virulent biofilms 
which are particularly difficult to eradicate [5-6]. Biofilm 
formation is an important bacterial survival strategy and, in 
humans, biofilms are responsible for numerous pathologies 
usually associated with the use of medical devices [7-8]. In this 
way, new alternative strategies to antibiotherapy are highly 
desired by the worldwide medical and scientific community 
and bacteriophages (phages) appear as one attractive solution 
for this problem [9-11].  
Phage therapy is based on the use of lytic phages to combat 
bacterial infections, including multi-drug resistant bacteria, 
and has many advantages comparatively to antibiotics: they are 
very specific and efficient for their target bacteria which 
reduces the destruction of the natural flora on the host; they are 
not pathogenic for man; and they need their target bacteria to 
grow and only persist as long as the bacteria they are targeting 
is present [9, 12]. 
II. GOALS 
The aim of this work was the isolation and characterization 
of novel P. aeruginosa phages and also the evaluation of their 
efficiency on planktonic cultures and mono-species biofilms. 
III. IMPLEMENTATION 
A. Isolation and characterization of phages 
Bacteriophages were isolated from 2 hospital effluents 
provided by Hospital de São João (Porto, Portugal). These 
effluents were enriched with 4 P. aeruginosa strains (ATCC 
10145, CECT 111, PAO 1 and a clinical isolate (CLIN)) in 2 × 
Tryptic Soy Broth (TSB) medium. This solution was incubated 
(37°C, 120 rpm) during 48 hours and then centrifuged to 
collect the supernatant for the spot tests (Fig. 1) indicative of 
the existence of phage(s). Each inhibition halo was further 
purified with toothpicks and papers, to isolate all different 
phages.  
 
 
 
 
Figure 1.  Examples of a spot test of enriched effleunt on lawns of P. 
aeruginosa ATCC 10145 and PAO 1. 
Overall, 17 phages with different characteristics were 
isolated and 4 of them were selected to perform planktonic 
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cells infection assays. This selection was done according to the 
results of the lytic spectra. To evaluate the lytic spectra of all 
isolated phages, each phage was tested against 35 different P. 
aeruginosa strains.  31 of these strains were clinical isolates 
provided by Hospital de São Marcos (Braga, Portugal). To 
perform the lytic spectra assay, one drop of each serial diluted 
phage suspension was placed into the different bacterial lawns 
and incubated overnight at 37°C. In the following day, the 
susceptibility of each host to the different phages was 
evaluated. 
SDS-PAGE experiment was also performed in order to 
analyze the structural proteins of the 4 selected phages. After 
the preparation of the gels, the samples were added and the gels 
were run at 100 V (80 mA). After electrophoresis, the gels 
were stained with silver nitrate.   
B. Phage infection 
1. Infection of planktonic cells 
The infection of planktonic cells was done in two different 
stages of bacterial growth – exponential and stationary phases. 
To perform the planktonic cell infections at the stationary 
stage, the 4 hosts were inoculated overnight in TSB medium at 
37°C (120 rpm). The resultant cellular suspensions were 
diluted with TSB medium in order to have an optical density 
(OD600nm) approximately 0.75. To do the planktonic cells 
infection at exponential stage, an overnight pre-inoculum was 
used to inoculate fresh TSB medium which were allowed to 
grow until achieving an optical density (OD600nm) of 0.5. In all 
experiments, phages were added to the respective hosts in 
order to obtain a multiplicity of infection (MOI) of 1. The 
control experiments were performed with SM Buffer instead of 
phages. The infection of planktonic cell assays were performed 
in 96-well microtiter plates (37°C, 120 rpm) and the optical 
density (OD600nm) was regularly read.   
2. Characterization of P. aeruginosa biofilms 
Based on the phage infection experiments of the planktonic 
cells, only P. aeruginosa ATCC 10145 and PAO 1 strains 
were used in biofilm assays. Biofilm formation was carried out 
in 24-well microplates containing 1 ml of Yeast Peptone 
Dextrose (YPD - 10 g l-1 Yeast Extract, 20 g l-1 Peptone, 20 g l-
1 Dextrose) medium and 10 µl of cellular suspension with an 
optical density (OD600nm) of 1.0. Biofilms were formed during 
24 hours with medium renewal every 12 hours and the plates 
were incubated at 37°C in an orbital shaker (120 rpm). The 
amounts of bacteria attached to the biofilms were determined 
by CFU counts using microdrop technique. Briefly, the wells 
of microplates were washed with saline solution (0.9% NaCl) 
to remove unattached bacteria and then 1 ml of fresh saline 
solution was added to each well and the biofilm scraped with a 
cell scrapper prior to sonication (5 min). After this, the cellular 
suspension of each well was removed, centrifuged (5 min, 
9,000 × g, 4°C) and the pellet resuspended in 1 ml of saline 
solution (0.9%). The samples were diluted in saline solution 
(0.9%) and one drop (10 µl) was placed into a Petri plate 
containing YPD solid medium and allowed to run down the 
plate. The plates were incubated at 37°C during 16 to 18 h and 
after the CFU’s were counted.  
3. Biofilm infection 
The biofilm infection was done with two different phages – 
phiIBB-PAA2 and phiIBB-PAP21. After 24 hours of biofilm 
formation, all the medium and planktonic bacteria were 
removed from each well and washed with fresh YPD medium. 
Following that, 500 µl of fresh YPD medium and 500 µl of 
phage solution or SM Buffer, in case of control experiments, 
were added. The multiplicity of infection (MOI) used for the 
experiments was 1. The plates were incubated in an orbital 
shaker (120 rpm) at 37°C and samples were taken after 2, 6 
and 24 hours of infection for CFU and PFU counts. The CFU 
counts were determined as previously described by microdrop 
technique and for PFU counting the Small Drop method 
described by Mazzoco et al. (2008) was used [13]. 
IV. RESULTS 
A. Phage characterization 
In the present study, 17 new phages for P. aeruginosa were 
isolated from hospital effluents using three collection strains 
and a clinical strain which were tested for efficiency against 35 
clinical strains. Most phages showed lytic activity against 
several clinical isolates, even against multi-resistant strains. 
The least efficient isolated phages were those with the clinical 
P. aeruginosa isolate as host where the percentages of strains 
infected varied between 17 and 54 percent, while the most 
efficient phages, the ones with CECT 111 as propagation 
strain, were capable of lysing approximately 60 to 89 percent 
of the clinical strains tested (data not shown). 
After lytic spectrum assays, one phage for each host was 
selected for further characterization and also for use in 
planktonic and biofilm infection experiments. The criteria used 
for this selection was the number of strains that each phage 
was able to infect. Accordingly, the selected phages were: 
phiIBB-PAA2, phiIBB-PAC23, phiIBB-PACL12 and phiIBB-
PAP21, respectively. Phages phiIBB-PAA2 and phiIBB-
PAP21 were analysed by Transmission Electron Microscopy 
and were found to belong to the “T7-like” genus of the 
Podoviridae family of phages (Fig. 2A). Phage structural 
proteins, analyzed by SDS-PAGE (Fig. 2B), showed that both 
phages phiIBB-PAC23 and phiIBB-PAP21 have a high degree 
of homology and thus belong also to the “T7-like” genus.  
 
 
 
 
 
 
 
 
 
Figure 2.  Characterization of phages A) Phage phiIBB-PAA2 observed by 
Transmission Electron Microscopy (TEM) (bar corresponds to 100 nm); B) 
SDS-page of structural proteins of P. aeruginosa phages phiIBB-PAA2, 
phiIBB-PAC23, phiIBB-PACL12 and phiIBB-PAP21 
A B 
B. Infection of planktonic cells 
After phage selection and characterization, phage infection 
experiments were performed in exponential growing and 
stationary cells (Fig. 3). There was a clear difference in the 
infection patterns after infection of cells at the stationary and 
exponential phases with the 4 different phages. Phage phiIBB-
PAA2 appeared to have a greater capacity of infecting P. 
aeruginosa host, followed by phage phiIBB-PAP21. Phage 
phiIBB-PACL12, although having a broad spectrum of activity 
in infecting of different isolates, did not cause a reduction of 
the optical density of neither exponentially growing nor 
stationary phase cells.  This suggests that although phages can 
be selected based on their broad activity, this doesn’t 
necessarily guarantee their effectiveness in controlling their 
respective host population. Nevertheless, two of the used 
phages, phages phiIBB-PAA2 and phiIBB-PAP21, were both 
efficient towards exponential as well as stationary phase cells 
and caused a reduction over 50% of  the initial optical density 
(OD600nm). 
Figure 3.  Infection of planktonic P. aeruginosa cultures with phages 
phiIBB-PAA2 (ATCC 10145), phiIBB-PAC23 (CECT 111), phiIBB-PACL12 
(CLIN) and phiIBB-PAP21 (PAO 1). A) Control experiments with stationary 
phase cultures; B) Control experiments with exponentially growing cells; C) 
Phage infection experiments with stationary cultures; D) Phage infection 
experiments with exponentially growing cultures. 
C. Biofilm infection 
It is expected that the phage infection in planktonic cells 
would be more efficient than in biofilms due to the biofilm 
architecture which difficult the access of phage into bacteria 
[14]. Due to the inefficient activity of phages phiIBB-PACL12 
and phiIBB-PAC23 against planktonic cultures, only two 
phages, phiIBB-PAA2 and phiIBB-PAP21, were chosen for P. 
aeruginosa biofilm infection assays.  
Before P. aeruginosa biofilm infection, the number of CFU 
counts of 24 hours biofilms of both strains chosen for this 
experiment were determined (Fig. 4) and presented similar 
results. 
 
 
 
 
 
Figure 4.  Enumeration of the number of viable cells present in P. aeruginosa 
ATCC and PAO 1 biofilms formed during 24 hours 
 
As previously described, the phage infection assays of P. 
aeruginosa ATCC 10145 and PAO1 were performed in 24 
hours old biofilms (Fig. 5). 
Both phages, tested against 24 hours old biofilms, caused a 
significant reduction on the biofilm cells already after 2 hours 
of infection and the reduction was further enhanced after 6 
hours of biofilm treatment reaching a reduction of almost 3 log 
with phage phiIBB-PAP21 and a 2 log reduction with phage 
phiIBB-PAA2 (Fig. 5A).  
 
Figure 5.  Infection of P. aeruginosa ATCC 10145 and PAO1 biofilms with 
phages phiIBB-PAA2 and phiIBB-PAP21, respectively. A) Number of viable 
cells before and after infection; B) Number of phages (PFU) attached to the 
biofilms; C) Number of phages (PFU) released from the infected biofilms. 
Despite the lower activity against planktonic cells, phage 
phiIBB-PAP21 caused a higher reduction of viable cells from 
the P. aeruginosa PAO1 biofilms after 2 and 6 hours of 
treatment than phage phiIBB-PAA2 in P. aeruginosa ATCC 
10145 biofilms. Similar reductions of viable cells have been 
observed for P. fluorescens phages [15] and there is only one  
work in literature where complete eradication of 24 hours 
Enterobacter cloace biofilms was achieved by a combination 
of 3 different phages [16]. The main difference between the 
two phages used in this work for P. aeruginosa biofilm control 
experiments concerns the resistance of the bacteria to the 
phages. The interaction of phages and bacteria during long 
periods of time can result in the emergence of phage resistant 
bacteria [17-18]. Biofilm cells of P. aeruginosa PAO1, the 
host of phage phiIBB-PAP21, acquired resistance to the phage 
resulting in an increase on the amount of cells after 24 hours of 
biofilm treatment (Fig. 5A). On the other hand, phage phiIBB-
PAA2 continued to destroy biofilm cells of P. aeruginosa 
ATCC 10145 and there were no evidences of cells becoming 
resistant, even after 24 hours of phage infection. 
One unexpected result obtained was in terms of the 
number of phages attached to the biofilms (and the surface of 
the well) measured by plaque forming units (PFU) counts 
(Fig. 5B). It appears that initially phage phiIBB-PAA2 
adsorbed to the biofilms, however after cell lysis the number 
of phages present in the biofilms decreased by almost 2 logs. 
Unlike with phage phiIBB-PAA2, the amount of phiIBB-
PAP21 phages continued to increase until 6 hours of infection, 
however, as in phiIBB-PAA2 experiments, there was again 
observed a significant decrease of the number of phages 
attached after 24 hours of biofilm cell infection. 
Overall, this work revealed the efficacy of phages in cell 
lysis even against multidrug resistant bacteria. Furthermore, 
both novel isolated phages were well capable of controlling P. 
aeruginosa biofilms. 
V. CONCLUSIONS 
In this study it was possible to conclude that most of the 
isolated phages have a great lytic capacity against P. 
aeruginosa clinical strains achieving high percentages of lysis.  
This study also revealed that phages may be a good 
alternative to traditional antimicrobials for the control of P. 
aeruginosa biofilms; however, short periods of treatment seem 
to be a better solution avoiding the emergence of phage 
resistant hosts. 
VI. PLANNED DEVELOPMENTS 
Some alternative approaches can be very interesting for the 
future work. The combination of phages with chemical agents 
such as detergents, disinfectants and antibiotics can result in a 
good option for the eradication of P. aeruginosa biofilms from 
different clinical surfaces. Another alternative strategy 
involves the use of a cocktail with different phages in order to 
obtain a solution with a greater range of action. Finally, the 
genetic manipulation of phages may also be an important 
future approach in order to obtain phages with broad lytic 
spectra and also with high ability to control resistant 
phenotypes. 
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